BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 27499366)

  • 1. Is there a role for gut microbiota in type 1 diabetes pathogenesis?
    Bibbò S; Dore MP; Pes GM; Delitala G; Delitala AP
    Ann Med; 2017 Feb; 49(1):11-22. PubMed ID: 27499366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The gut microbiota and Type 1 Diabetes.
    Gülden E; Wong FS; Wen L
    Clin Immunol; 2015 Aug; 159(2):143-53. PubMed ID: 26051037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbiota and Type 1 Diabetes.
    Han H; Li Y; Fang J; Liu G; Yin J; Li T; Yin Y
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29584630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current understanding of the role of gut dysbiosis in type 1 diabetes.
    Abdellatif AM; Sarvetnick NE
    J Diabetes; 2019 Aug; 11(8):632-644. PubMed ID: 30864231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal dysbiosis and probiotic applications in autoimmune diseases.
    de Oliveira GLV; Leite AZ; Higuchi BS; Gonzaga MI; Mariano VS
    Immunology; 2017 Sep; 152(1):1-12. PubMed ID: 28556916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting gut microbiota as a possible therapy for diabetes.
    He C; Shan Y; Song W
    Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the pathogenesis of insulin-dependent diabetes mellitus: the role of microbiota.
    Gianchecchi E; Fierabracci A
    Immunol Res; 2017 Feb; 65(1):242-256. PubMed ID: 27421719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiome dysbiosis and increased intestinal permeability in children with islet autoimmunity and type 1 diabetes: A prospective cohort study.
    Harbison JE; Roth-Schulze AJ; Giles LC; Tran CD; Ngui KM; Penno MA; Thomson RL; Wentworth JM; Colman PG; Craig ME; Morahan G; Papenfuss AT; Barry SC; Harrison LC; Couper JJ
    Pediatr Diabetes; 2019 Aug; 20(5):574-583. PubMed ID: 31081243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
    Rizzetto L; Fava F; Tuohy KM; Selmi C
    J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Alterations in the Gut Microbiota and Intestinal Permeability in Patients With Hashimoto Thyroiditis.
    Cayres LCF; de Salis LVV; Rodrigues GSP; Lengert AVH; Biondi APC; Sargentini LDB; Brisotti JL; Gomes E; de Oliveira GLV
    Front Immunol; 2021; 12():579140. PubMed ID: 33746942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Triple Interaction between the Host Genome, the Epigenome, and the Gut Microbiome in Type 1 Diabetes.
    Elhag DA; Kumar M; Al Khodor S
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the origin of type 1 diabetes in the gut?
    Vaarala O
    Immunol Cell Biol; 2012 Mar; 90(3):271-6. PubMed ID: 22290506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diet, Microbiota and Immune System in Type 1 Diabetes Development and Evolution.
    Mejía-León ME; Barca AM
    Nutrients; 2015 Nov; 7(11):9171-84. PubMed ID: 26561831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between intestinal permeability and faecal microbiota composition in Italian children with beta cell autoimmunity at risk for type 1 diabetes.
    Maffeis C; Martina A; Corradi M; Quarella S; Nori N; Torriani S; Plebani M; Contreas G; Felis GE
    Diabetes Metab Res Rev; 2016 Oct; 32(7):700-709. PubMed ID: 26891226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases.
    Lin L; Zhang J
    BMC Immunol; 2017 Jan; 18(1):2. PubMed ID: 28061847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gut as a regulator of early inflammation in type 1 diabetes.
    Vaarala O
    Curr Opin Endocrinol Diabetes Obes; 2011 Aug; 18(4):241-7. PubMed ID: 21681088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment.
    Dolpady J; Sorini C; Di Pietro C; Cosorich I; Ferrarese R; Saita D; Clementi M; Canducci F; Falcone M
    J Diabetes Res; 2016; 2016():7569431. PubMed ID: 26779542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiota derived factors as drivers of type 1 diabetes.
    Tillett BJ; Hamilton-Williams EE
    Prog Mol Biol Transl Sci; 2020; 171():215-235. PubMed ID: 32475523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The intricate association between gut microbiota and development of type 1, type 2 and type 3 diabetes.
    Bekkering P; Jafri I; van Overveld FJ; Rijkers GT
    Expert Rev Clin Immunol; 2013 Nov; 9(11):1031-41. PubMed ID: 24138599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond genetics. Influence of dietary factors and gut microbiota on type 1 diabetes.
    Nielsen DS; Krych Ł; Buschard K; Hansen CH; Hansen AK
    FEBS Lett; 2014 Nov; 588(22):4234-43. PubMed ID: 24746688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.